Stories
Slash Boxes
Comments

SoylentNews is people

posted by hubie on Sunday August 07 2022, @05:05AM   Printer-friendly

The new treatment was 80 to 100 percent effective in a phase 1 trial:

Methods for preventing malaria infections range from the low-tech, like mosquito bed nets and getting rid of standing water; to the uncannily high-tech, like genetically engineering sterile male mosquitoes and introducing them for population control. The World Health Organization approved a vaccine called Mosquirix in October 2021, but the shot is only 30 percent effective at preventing cases of severe malaria.

A new player may soon be entering the field: monoclonal antibodies, a lab-grown treatment that has shown promise for a wide variety of conditions, including cancer and COVID-19. Results from a phase 1 clinical trial published Wednesday in The New England Journal of Medicine indicate that infusions and injections of a monoclonal antibody tailor-made for malaria are safe, and offer hints that the treatment could be highly effective.

[...] Still, it's too early to say how much of a game changer this treatment could be—in part because practical constraints could make it difficult to deliver monoclonal antibody treatments to those in need. "The current trial included intravenous administration, which is appropriate in an experimental setting but of questionable use in the field," malaria researchers Timothy Wells and Cristina Donini wrote in an editorial accompanying the study. The cost of the treatment is another consideration, though current estimates put the antibodies' price within a similar range as the vaccine.

[...] "Elimination is the aspiration," he said.

Journal Reference:
Richard L. Wu, Azza H. Idris, Nina M. Berkowitz, et al., Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria [open], N Engl J Med, 2022. DOI: 10.1056/NEJMoa2203067


Original Submission

This discussion was created by hubie (1068) for logged-in users only, but now has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
(1)
  • (Score: 1, Insightful) by Anonymous Coward on Sunday August 07 2022, @07:10AM (2 children)

    by Anonymous Coward on Sunday August 07 2022, @07:10AM (#1265395)

    The cost of the treatment is another consideration

    No, profit is the aspiration.

    • (Score: 4, Funny) by c0lo on Sunday August 07 2022, @10:43AM

      by c0lo (156) Subscriber Badge on Sunday August 07 2022, @10:43AM (#1265418) Journal

      "Elimination is the aspiration"
      ...
      No, profit is the aspiration.

      Agreed, it is the expiration that is closer to eliminating something that one aspired [webmd.com]. In cases of extreme profit involved in the aspiration, the Heimlich maneuver may be the way to go.

      --
      https://www.youtube.com/watch?v=aoFiw2jMy-0 https://soylentnews.org/~MichaelDavidCrawford
    • (Score: 2) by MIRV888 on Monday August 08 2022, @05:28AM

      by MIRV888 (11376) on Monday August 08 2022, @05:28AM (#1265505)

      20 years and generics become available. Badda Bing! Malaria is a preventable disease on earth. Until then it's just for the wealthy.
      So.. the status quo.
      Money talks and bullshit (poors) walk.

  • (Score: 2) by krishnoid on Sunday August 07 2022, @06:15PM (1 child)

    by krishnoid (1156) on Sunday August 07 2022, @06:15PM (#1265449)

    "A shot of antibodies?" It's a great start. Some of the smartest people on the planet are doing medical research and diagnostics [youtu.be], and they probably don't know enough about marketing to run a soda vending machine on a hot day. How about the "America Trump Lets Go Brandon Freedom Strengthener Dose"?

(1)